Sartorius AG/ADR (SOAGY)
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Industry: Medical - Instruments & Supplies
Sartorius AG ADR
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
No company description available.
Leadership
Rene Faber
Head of Bioprocess Solutions Division & Member of Executive Board
Florian Funck
Chief Financial Officer & Member of Executive Board
Alexandra Gatzemeyer
Head of the Lab Products & Services Division and Member of Executive Board
Michael Grosse
Chief Executive Officer & Chairman of the Executive Board
Employees
--
Country
--
Sector
Healthcare
Website
--
| Name | Shares | % | Source |
|---|---|---|---|
NANO CAP NEW MILLENNIUM GROWTH FUND L P | 12.5K | -- | 13F |
RHUMBLINE ADVISERS | 505 | -- | 13F |
GAMMA Investing LLC | 211 | -- | 13F |
Salomon & Ludwin, LLC | 85 | -- | 13F |
Top institutional holders
30d Avg
9.85K
60d Avg
7.71K
90d Avg
6.62K